LeonaBio (LONA) Enterprise Value (2019 - 2026)

LeonaBio (LONA) has 8 years of Enterprise Value data on file, last reported at -$67.7 million in Q1 2026.

• On a quarterly basis, Enterprise Value fell 84.56% year-over-year to -$67.7 million in Q1 2026; TTM through Mar 2026 was -$67.7 million, a 84.56% decrease from a year earlier, with the FY2025 full-year figure at -$88.3 million, down 72.27% from the prior year.
• Enterprise Value for Q1 2026 stood at -$67.7 million, up from -$88.3 million in the prior quarter.
• Over the last five years, Enterprise Value for LONA reached as high as -$25.2 million in Q3 2025 and fell as low as -$263.5 million in Q1 2022.
• Historically, Enterprise Value has averaged -$130.0 million across 5 years, with a median of -$122.1 million in 2024.
• Across the five-year window, Enterprise Value soared 69.96% in 2025 and tumbled 84.56% in 2026, its largest moves.
• Year by year, Enterprise Value stood at -$200.3 million in 2022, then advanced by 26.42% to -$147.4 million in 2023, then surged by 65.22% to -$51.3 million in 2024, then slumped by 72.27% to -$88.3 million in 2025, then grew by 23.38% to -$67.7 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$67.7 million in Q1 2026, -$88.3 million in Q4 2025, and -$25.2 million in Q3 2025.